Cargando…
Perifollicular Xanthoma Occurring in Patients after Erlotinib Treatment
Erlotinib (Tarceva(®)) is a drug used for the treatment of non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) mutations. Since EGFR is expressed in the skin, EGFR inhibitors commonly develop cutaneous side effects such as acneiform eruption, paronychia, telangiectasi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110603/ https://www.ncbi.nlm.nih.gov/pubmed/35508798 http://dx.doi.org/10.1007/s13555-022-00739-5 |